scholarly journals P196 Healthcare utilisation by patients with Idiopathic Pulmonary Fibrosis; observations from the UK pirfenidone Named Patient Programme

Thorax ◽  
2013 ◽  
Vol 68 (Suppl 3) ◽  
pp. A164.3-A165 ◽  
Author(s):  
H Parfrey ◽  
C Leonard ◽  
MA Gibbons ◽  
E Armstrong ◽  
E Harris ◽  
...  
Keyword(s):  
Idiopathic Pulmonary Fibrosis ◽  
Pulmonary Fibrosis ◽  
Healthcare Utilisation ◽  
Named Patient Programme ◽  
The Uk

scholarly journals P272 Epidemiology of idiopathic pulmonary fibrosis in the uk: findings from the british lung foundation’s ‘respiratory health of the nation’ project

Thorax ◽  
2016 ◽  
Vol 71 (Suppl 3) ◽  
pp. A236.1-A236 ◽  
Author(s):  
N Snell ◽  
D Strachan ◽  
R Hubbard ◽  
J Gibson ◽  
T Maher ◽  
...  
Keyword(s):  
Idiopathic Pulmonary Fibrosis ◽  
Pulmonary Fibrosis ◽  
Respiratory Health ◽  
The Uk

scholarly journals S98 Early Clinical Experience with Pirfenidone For Idiopathic Pulmonary Fibrosis (IPF) in the UK: Interim Results from a UK Cohort

Thorax ◽  
2012 ◽  
Vol 67 (Suppl 2) ◽  
pp. A48.2-A49 ◽  
Author(s):  
H Parfrey ◽  
C Leonard ◽  
MA Gibbons ◽  
E Harris ◽  
R Frank ◽  
...  
Keyword(s):  
Idiopathic Pulmonary Fibrosis ◽  
Pulmonary Fibrosis ◽  
Clinical Experience ◽  
Early Clinical Experience ◽  
The Uk

scholarly journals Nintedanib Cost-Effectiveness In Idiopathic Pulmonary Fibrosis In The UK

2016 ◽  
Vol 19 (7) ◽  
pp. A553 ◽  
Author(s):  
C Rinciog ◽  
M Watkins ◽  
S Chang ◽  
T Maher ◽  
C LeReun ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Idiopathic Pulmonary Fibrosis ◽  
Pulmonary Fibrosis ◽  
The Uk

Idiopathic pulmonary fibrosis: a more common condition than you may think

2021 ◽  
Vol 30 (6) ◽  
pp. 359-366
Author(s):  
Penny Tremayne ◽  
Samuel John Clark
Keyword(s):  
Idiopathic Pulmonary Fibrosis ◽  
Pulmonary Fibrosis ◽  
Health Professionals ◽  
Treatment Options ◽  
Delayed Diagnosis ◽  
Common Condition ◽  
Inadequate Care ◽  
Definition Of ◽  
The Uk ◽  
Causes And Risk Factors

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive incurable lung disease that affects a significant amount of people in the UK. Many health professionals have a limited understanding of IPF, which can result in a delayed diagnosis and inadequate care for individuals and their families. This article aims to provide an overview of IPF and help to enhance health professionals' understanding of the disease, thus contributing towards improving the care that IPF sufferers receive. This article provides a definition of IPF and explores its pathophysiology. It discusses the causes and risk factors for developing the condition, examines how IPF is diagnosed and details the treatment options available for IPF patients.

scholarly journals Healthcare utilisation and costs in the diagnosis and treatment of progressive-fibrosing interstitial lung diseases

2018 ◽  
Vol 27 (150) ◽  
pp. 180078 ◽  
Author(s):  
Colin Holtze ◽  
Kevin Flaherty ◽  
Michael Kreuter ◽  
Fabrizio Luppi ◽  
Teng Moua ◽  
...  
Keyword(s):  
Lung Function ◽  
Idiopathic Pulmonary Fibrosis ◽  
Pulmonary Fibrosis ◽  
Healthcare Costs ◽  
Lung Diseases ◽  
Healthcare Utilisation ◽  
Interstitial Lung Diseases ◽  
Early Mortality ◽  
Disease Course ◽  
Few Data

There are over 200 interstitial lung diseases (ILDs). In addition to patients with idiopathic pulmonary fibrosis (IPF), a percentage of patients with other ILDs also develop progressive fibrosis of the lung during their disease course. Patients with progressive-fibrosing ILDs may show limited response to immunomodulatory therapy, worsening symptoms and lung function and, ultimately, early mortality. There are few data for ILDs that may present a progressive fibrosing phenotype specifically, but we believe the burden and healthcare costs associated with these conditions may be comparable to those reported in IPF. This review discusses the burden of ILDs that may present a progressive fibrosing phenotype and the factors impacting healthcare utilisation.

scholarly journals Improving care for patients with idiopathic pulmonary fibrosis (IPF) in the UK: a round table discussion

Thorax ◽  
2014 ◽  
Vol 69 (12) ◽  
pp. 1136-1140 ◽  
Author(s):  
David R Thickett ◽  
Clare Kendall ◽  
Lisa G Spencer ◽  
Nick Screaton ◽  
William A Wallace ◽  
...  
Keyword(s):  
Idiopathic Pulmonary Fibrosis ◽  
Pulmonary Fibrosis ◽  
Round Table ◽  
Round Table Discussion ◽  
Table Discussion ◽  
The Uk
Sign in / Sign up

Export Citation Format

Share Document